🇺🇸 FDA
Pipeline program

SSGJ-706

SSGJ-706-101

Phase 1 small_molecule active

Quick answer

SSGJ-706 for Advanced Solid Tumors Patients is a Phase 1 program (small_molecule) at Sunshine Biopharma with 1 ClinicalTrials.gov record(s).

Program details

Company
Sunshine Biopharma
Indication
Advanced Solid Tumors Patients
Phase
Phase 1
Modality
small_molecule
Status
active

Clinical trials